High prevalence of gastroesophageal reflux symptoms in type 2 diabetics with hypoadiponectinemia and metabolic syndrome

Nutrition and Metabolism

Volumn 9, Issue , 2012, Pages

  Hirata, Ayumu ^a   Kishida, Ken ^a   Nakatsuji, Hideaki ^a   Inoue, Kana ^a   Hiuge Shimizu, Aki ^a   Funahashi, Tohru ^a   Shimomura, Iichiro ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

adiponectin; gastroesophageal reflux symptom; metabolic syndrome; visceral fat

Indexed keywords

ADIPONECTIN;

ABDOMINAL OBESITY; ABNORMALLY LOW SUBSTRATE CONCENTRATION IN BLOOD; ADULT; AGED; ARTICLE; BIOELECTRICAL IMPEDANCE ANALYSIS; BODY FAT DISTRIBUTION; DISEASE ASSOCIATION; FEMALE; FREQUENCY SCALE FOR THE SYMPTOMS OF GERD QUESTIONNAIRE; GASTROESOPHAGEAL REFLUX; HUMAN; HYPOADIPONECTINEMIA; IMPEDANCE; JAPANESE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN BLOOD LEVEL; QUESTIONNAIRE;

EID: 84856092758     PISSN: None     EISSN: 17437075     Source Type: Journal    
DOI: 10.1186/1743-7075-9-4     Document Type: Article

References (25)

1. Racial and geographic issues in gastroesophageal reflux disease. Sharma P, Wani S, Romero Y, Johnson D, Hamilton F, Am J Gastroenterol 2008 103 2669 80 10.1111/j.1572-0241.2008.02089.x 19032462
2. Environmental-lifestyle related factors. Roman S, Pandolfino JE, Best Pract Res Clin Gastroenterol 2010 24 847 59 10.1016/j.bpg.2010.09.010 21126698
3. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Hampel H, Abraham NS, El-Serag HB, Ann Intern Med 2005 143 199 211 16061918 (Pubitemid 41076753)
4. Obesity and gastroesophageal reflux: quantifying the association between body mass index, esophageal acid exposure, and lower esophageal sphincter status in a large series of patients with reflux symptoms. Ayazi S, Hagen JA, Chan LS, DeMeester SR, Lin MW, Ayazi A, Leers JM, Oezcelik A, Banki F, Lipham JC, DeMeester TR, Crookes PF, J Gastrointest Surg 2009 13 1440 47 10.1007/s11605-009-0930-7 19475461
5. Association between erosive esophagitis and visceral fat accumulation quantified by abdominal CT scan. Lee HL, Eun CS, Lee OY, Jeon YC, Han DS, Yoon BC, Choi HS, Hahm JS, Ahn YH, Song SY, J Clin Gastroenterol 2009 43 240 3 10.1097/MCG.0b013e318167b88a 18978505
6. Metabolic syndrome and visceral obesity as risk factors for reflux oesophagitis: a cross-sectional case-control study of 7078 Koreans undergoing health check-ups. Chung SJ, Kim D, Park MJ, Kim YS, Kim JS, Jung HC, Song IS, Gut 2008 57 1360 5 10.1136/gut.2007.147090 18441006
7. Association of low serum adiponectin levels with erosive esophagitis in men: an analysis of 2405 subjects undergoing physical check-ups. Kato M, Watabe K, Hamasaki T, Umeda M, Furubayashi A, Kinoshita K, Kishida O, Fujimoto T, Yamada A, Tsukamoto Y, Yamamoto S, Kamada Y, Yoshida Y, Kiso S, Tsutsui S, Kihara S, Hayashi N, Matsuzawa Y, J Gastroenterol 2011 46 1361 7 10.1007/s00535-011-0453-3 21845377
8. Decreased levels of adiponectin in obese patients with gastroesophageal reflux evaluated by videoesophagography: possible relationship between gastroesophageal reflux and metabolic syndrome. Iwasaki E, Suzuki H, Sugino Y, Iida T, Nishizawa T, Masaoka T, Hosoda H, Kangawa K, Hibi T, J Gastroenterol Hepatol 2008 23 216 21 19120901
9. Association between reflux oesophagitis and features of the metabolic syndrome in Japan. Moki F, Kusano M, Mizuide M, Shimoyama Y, Kawamura O, Takagi H, Imai T, Mori M, Aliment Pharmacol Ther 2007 26 1069 75 10.1111/j.1365-2036. 2007.03454.x 17877514 (Pubitemid 47416298)
10. Gastroesophageal reflux disease related to diabetes: Analysis of 241 cases with type 2 diabetes mellitus. Nishida T, Tsuji S, Tsujii M, Arimitsu S, Sato T, Haruna Y, Miyamoto T, Kanda T, Kawano S, Hori M, J Gastroenterol Hepatol 2004 19 258 65 10.1111/j.1440-1746.2003.03288.x 14748871 (Pubitemid 38338733)
11. Symptoms of gastroesophageal reflux in diabetes patients. Kase H, Hattori Y, Sato N, Banba N, Kasai K, Diabetes Res Clin Pract 2008 79 6 7 10.1016/j.diabres.2007.08.019 17904682
12. Prevalence of GORD (gastro-oesophageal reflux disease) in Type 2 diabetes and a comparison of clinical profiles between diabetic patients with and without GORD. Horikawa A, Ishii-Nozawa R, Ohguro M, Takagi S, Ohtuji M, Yamada M, Kuzuya N, Ujihara N, Ujihara M, Takeuchi K, Diabet Med 2009 26 228 33 10.1111/j.1464-5491.2009.02671.x 19317816
13. Clinical esophageal pH recording: a technical review for practice guideline development. Kahrilas PJ, Quigley EM, Gastroenterology 1996 110 1982 96 10.1053/gast.1996.1101982 8964428 (Pubitemid 26169239)
14. The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. Carlsson R, Dent J, Bolling-Sternevald E, Johnsson F, Junghard O, Lauritsen K, Riley S, Lundell L, Scand J Gastroenterol 1998 33 1023 9 10.1080/003655298750026697 9829354 (Pubitemid 28505643)
15. Comparison of endoscopic findings with symptom assessment systems (FSSG and QUEST) for gastroesophageal reflux disease in Japanese centres. Danjo A, Yamaguchi K, Fujimoto K, Saitoh T, Inamori M, Ando T, Shimatani T, Adachi K, Kinjo F, Kuribayashi S, Mitsufuji S, Fujiwara Y, Koyama S, Akiyama J, Takagi A, Manabe N, Miwa H, Shimoyama Y, Kusano M, J Gastroenterol Hepatol 2009 24 633 638 10.1111/j.1440-1746.2008.05747.x 19220681
16. Development and evaluation of FSSG: frequency scale for the symptoms of GERD. Kusano M, Shimoyama Y, Sugimoto S, Kawamura O, Maeda M, Minashi K, Kuribayashi S, Higuchi T, Zai H, Ino K, Horikoshi T, Sugiyama T, Toki M, Ohwada T, Mori M, J Gastroenterol 2004 39 888 91 10.1007/s00535-004-1417-7 15565409 (Pubitemid 39409671)
17. A new simple method for the measurement of visceral fat accumulation by bioelectrical impedance. Ryo M, Maeda K, Onda T, Katashima M, Okumiya A, Nishida M, Yamaguchi T, Funahashi T, Matsuzawa Y, Nakamura T, Shimomura I, Diabetes Care 2005 28 451 3 10.2337/diacare.28.2.451 15677816 (Pubitemid 40170963)
18. Three-month treatment with pioglitazone reduces circulating levels of thiobarbituric acid-reacting substances, a marker of reactive oxidative stress, without change in body mass index, in Japanese patients with type 2 diabetes. Nakatsuji H, Kishida K, Funahashi T, Shimomura I, Senri Study II Group, Atherosclerosis 2010 212 243 5 10.1016/j.atherosclerosis.2010.05.025 20541758
19. Selective contribution of waist circumference reduction on the improvement of sleep-disordered breathing in patients hospitalized with type 2 diabetes mellitus. Kashine S, Kishida K, Funahashi T, Yasuda T, Okita K, Matsuzawa Y, Shimomura I, Intern Med 2011 50 1895 903 10.2169/internalmedicine. 50.5669 21921366
20. Qualitative score of systemic arteriosclerosis by vascular ultrasonography as a predictor of coronary artery disease in type 2 diabetes. Hirata A, Kishida K, Hiuge-Shimizu A, Nakatsuji H, Funahashi T, Shimomura I, Atherosclerosis 2011 219 623 9 10.1016/j.atherosclerosis.2011.08.043 21930272
21. Metabolic syndrome. Teramoto T, Sasaki J, Ueshima H, Egusa G, Kinoshita M, Shimamoto K, Daida H, Biro S, Hirobe K, Funahashi T, Yokote K, Yokode M, J Atheroscler Thromb 2008 15 1 5 10.5551/jat.E580 18319538
22. Absolute value of bioelectrical impedance analysis-measured visceral fat area with obesity-related cardiovascular risk factors in Japanese workers. Okauchi Y, Kishida K, Funahashi T, Noguchi M, Ogawa T, Ryo M, Okita K, Iwahashi H, Imagawa A, Nakamura T, Matsuzawa Y, Shimomura I, J Atheroscler Thromb 2010 17 1237 45 10.5551/jat.5694 20834192
23. Adiponectin as an anti-inflammatory factor. Ouchi N, Walsh K, Clin Chim Acta 2007 380 24 30 10.1016/j.cca.2007.01.026 17343838 (Pubitemid 46498041)
24. Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Spranger J, Kroke A, Möhlig M, Hoffmann K, Bergmann MM, Ristow M, Boeing H, Pfeiffer AF, Diabetes 2003 52 812 7 10.2337/diabetes.52.3.812 12606524 (Pubitemid 36323590)
25. Gastroesophageal reflux disease-associated esophagitis induces endogenous cytokine production leading to motor abnormalities. Rieder F, Cheng L, Harnett KM, Chak A, Cooper GS, Isenberg G, Ray M, Katz JA, Catanzaro A, O'Shea R, Post AB, Wong R, Sivak MV, McCormick T, Phillips M, West GA, Willis JE, Biancani P, Fiocchi C, Gastroenterology 2007 132 154 65 10.1053/j.gastro.2006.10.009 17241868 (Pubitemid 46108733)